All stock lists
Seer, Inc. (NASDAQ:SEER)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
1.95-0.03 (-1.27%)
Insider Score
––Not scored
SEER Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
SEER Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 3.10 M | 2.71 M | 4.07 M | 3.97 M | 3.93 M | 4.14 M |
| Revenue Growth (YoY) | -21.11 % | -34.72 % | 3.14 % | 0.68 % | 27.99 % | 35.19 % |
| Cost of Revenue | 1.60 M | 1.81 M | 2.02 M | 2.01 M | 1.94 M | 2.14 M |
| Gross Profit | 1.51 M | 895.00 K | 2.06 M | 1.96 M | 1.99 M | 2.00 M |
| SG&A Expense | 10.14 M | 9.43 M | 9.83 M | 10.66 M | 10.66 M | 11.44 M |
| R&D Expense | 8.21 M | 8.81 M | 9.74 M | 10.80 M | 11.98 M | 11.35 M |
| Operating Expenses | 18.35 M | 18.15 M | 19.44 M | 21.30 M | 22.52 M | 22.73 M |
| Operating Income | -16.84 M | -17.26 M | -17.39 M | -19.35 M | -20.53 M | -20.73 M |
| Pretax Income | -16.89 M | -16.83 M | -15.97 M | -18.21 M | -19.38 M | -19.85 M |
| Tax Provision | 9.00 K | 10.00 K | 28.00 K | 24.00 K | 48.00 K | 101.00 K |
| Net Income | -16.90 M | -16.84 M | -15.99 M | -18.23 M | -19.42 M | -19.95 M |
| EPS (Basic) | -0.31 | -0.30 | -0.29 | -0.32 | -0.33 | -0.34 |
| EPS (Diluted) | -0.31 | -0.30 | -0.29 | -0.32 | -0.33 | -0.34 |
| Shares Outstanding | 55.16 M | 56.00 M | 57.45 M | 56.31 M | 58.09 M | 59.41 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.